Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
The recent sequencing of mammalian genomes has driven the development of genomic technologies, including microarray-based gene expression profiling, that allow simultaneous measurement of the expression levels of thousands of genes. Gene expression profiling applied to toxicology (toxicogenomics) has the potential to reveal, holistically, the molecular pathways and cellular processes that mediate the adverse responses to a toxicant. However, the initial output of a toxicogenomics experiment consists of a list of genes whose expression is altered upon toxicant exposure. In order to interpret these data in a biological context, new bioinformatic methods must be developed to place gene expression changes in the context of the underlying pathways and processes affected. One emerging approach is the application of Gene Ontology (GO) mapping and pathway analysis to gene expression profiling data. The utility of this in mechanistic toxicology will be illustrated using examples in which GO mapping of toxicogenomic data has provided novel insights into the molecular mechanisms induced by exposure to xenoestrogens.
Currie
Richard A
RA
Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield SK10 4TJ, UK. richard.currie@syngenta.com
Orphanides
George
G
Moggs
Jonathan G
JG
D000818:Animals; D001681:Biological Assay; D030541:Databases, Genetic; D004968:Estrogens, Non-Steroidal / Q000633:toxicity*; D005260:Female; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D020022:Genetic Predisposition to Disease; D023281:Genomics / Q000379:methods*; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010641:Phenotype; D040901:Proteomics / Q000379:methods; D043922:Toxicogenetics / Q000379:methods*; D014599:Uterus / Q000187:drug effects / Q000254:growth & development
D004968:Estrogens, Non-Steroidal